CGL
Clarius Group LLC Portfolio holdings
AUM
$1.72B
This Quarter Return
+23.51%
1 Year Return
+14.66%
3 Year Return
+85.31%
5 Year Return
+125.74%
10 Year Return
–
AUM
$714M
AUM Growth
+$714M
(+35%)
Cap. Flow
+$63.2M
Cap. Flow
% of AUM
8.85%
Top 10 Holdings %
Top 10 Hldgs %
57.32%
Holding
301
New
45
Increased
146
Reduced
77
Closed
18
Top Buys
| 1 |
Starbucks
SBUX
|
$29.3M |
| 2 |
Schwab Short-Term US Treasury ETF
SCHO
|
$13.6M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$7.2M |
| 4 |
Microsoft
MSFT
|
$6.76M |
| 5 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
$5.29M |
Top Sells
Sector Composition
| 1 | Technology | 18.77% |
| 2 | Consumer Discretionary | 15.45% |
| 3 | Industrials | 15.43% |
| 4 | Communication Services | 5.22% |
| 5 | Healthcare | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Broadcom
AVGO
$1.39T
| $1.73M | 0.24% |
5,476
-88
| -2% | -$27.8K |
|
52
PepsiCo
PEP
$207B
| $1.64M | 0.23% |
12,429
+692
| +6% | +$91.5K |
|
53
iShares Core MSCI Total International Stock ETF
IXUS
$47.4B
| $1.62M | 0.23% |
29,648
+15
| +0.1% | +$818 |
|
54
Bank of America
BAC
$371B
| $1.6M | 0.22% |
67,250
-17,834
| -21% | -$424K |
|
55
Walmart
WMT
$778B
| $1.55M | 0.22% |
12,948
+1,107
| +9% | +$133K |
|
56
Coca-Cola
KO
$297B
| $1.55M | 0.22% |
34,689
-3,452
| -9% | -$154K |
|
|
SAGE
57
DELISTED
Sage Therapeutics
SAGE
| $1.48M | 0.21% |
35,500
| – | – |
|
58
Comcast
CMCSA
$126B
| $1.47M | 0.21% |
37,641
+2,321
| +7% | +$90.5K |
|
59
Amgen
AMGN
$154B
| $1.46M | 0.21% |
6,201
+748
| +14% | +$176K |
|
60
Thermo Fisher Scientific
TMO
$183B
| $1.44M | 0.2% |
3,963
+746
| +23% | +$270K |
|
61
Adaptive Biotechnologies
ADPT
$1.95B
| $1.43M | 0.2% |
29,596
| – | – |
|
62
Abbott
ABT
$228B
| $1.42M | 0.2% |
15,576
+2,281
| +17% | +$209K |
|
63
AbbVie
ABBV
$375B
| $1.36M | 0.19% |
13,879
+3,824
| +38% | +$376K |
|
64
Chevron
CVX
$325B
| $1.36M | 0.19% |
15,251
-8,003
| -34% | -$714K |
|
65
Pfizer
PFE
$141B
| $1.34M | 0.19% |
41,029
+1,382
| +3% | +$45.2K |
|
66
iShares Russell 1000 Growth ETF
IWF
$115B
| $1.34M | 0.19% |
6,957
-5,877
| -46% | -$1.13M |
|
67
Accenture
ACN
$159B
| $1.25M | 0.17% |
5,805
+746
| +15% | +$160K |
|
68
Invesco QQQ Trust
QQQ
$360B
| $1.23M | 0.17% |
4,952
-11
| -0.2% | -$2.72K |
|
69
Eli Lilly
LLY
$660B
| $1.18M | 0.17% |
7,178
+620
| +9% | +$102K |
|
70
American Tower
AMT
$93.4B
| $1.17M | 0.16% |
4,509
+633
| +16% | +$164K |
|
71
Exxon Mobil
XOM
$490B
| $1.17M | 0.16% |
26,078
-2,621
| -9% | -$117K |
|
72
Bristol-Myers Squibb
BMY
$96.4B
| $1.14M | 0.16% |
19,388
+2,342
| +14% | +$138K |
|
73
Danaher
DHR
$145B
| $1.14M | 0.16% |
6,437
+420
| +7% | +$74.3K |
|
74
Oracle
ORCL
$628B
| $1.12M | 0.16% |
20,329
+1,304
| +7% | +$72.1K |
|
75
Union Pacific
UNP
$131B
| $1.1M | 0.15% |
6,517
-145
| -2% | -$24.5K |
|